Navigation Links
Most-used diabetes drug works in different way than previously thought
Date:1/6/2013

PHILADELPHIA - A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, found that the diabetes drug metformin works in a different way than previously understood. Their research in mice found that metformin suppresses the liver hormone glucagon's ability to generate an important signaling molecule, pointing to new drug targets. The findings were published online this week in Nature.

For fifty years, one of the few classes of therapeutics effective in reducing the overactive glucose production associated with diabetes has been the biguanides, which includes metformin, the most frequently prescribed drug for type 2 diabetes. The inability of insulin to keep liver glucose output in check is a major factor in the high blood sugar of type 2 diabetes and other diseases of insulin resistance.

"Overall, metformin lowers blood glucose by decreasing liver production of glucose," says Birnbaum. "But we didn't really know how the drug accomplished that."

Imperfectly Understood

Despite metformin's success, its mechanism of action remained imperfectly understood. About a decade ago, researchers suggested that metformin reduces glucose synthesis by activating the enzyme AMPK. But this understanding was challenged by genetic experiments in 2010 by collaborators on the present Nature study. Coauthors Marc Foretz and Benoit Viollet from Inserm, CNRS, and Universit Paris Descartes, Paris, found that the livers of mice without AMPK still responded to metformin, indicating that blood glucose levels were being controlled outside of the AMPK pathway.

Taking another look at how glucose is regulated normally, the team knew that when there is no food intake and glucose decreases, glucagon is secreted from the pancreas to signal the liver to produce glucose. Th
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Page: 1 2

Related biology news :

1. UCSB researchers perform pioneering research on Type 2 diabetes
2. NTU study finds ways to prevent muscle loss, obesity and diabetes
3. Notre Dame research may have important implications for combating diabetes
4. University of Chicagos Graeme Bell receives international diabetes prize
5. Joslin researchers increase understanding of genetic risk factor for type 1 diabetes
6. Arginine and proline enriched diet may speed wound healing in diabetes
7. Diabetes Management Provider ActiveCare Announces Cost Savings Of Over $4,000 Per Year Per Diabetic Member
8. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
9. Risk of developing diabetes higher in neighborhoods that arent walk-friendly: Study
10. Cystic fibrosis disrupts pancreas two ways in CF-related diabetes
11. Shedding new light on one of diabetes most dangerous complications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Most-used diabetes drug works in different way than previously thought
(Date:11/4/2014)... LAKE CITY, Nov. 5, 2014 – University of Utah ... enzymes to help jet fuel produce electricity without needing ... be used to power portable electronics, off-grid power and ... online today in the American Chemical Society journal ... electricity through a chemical reaction between a fuel and ...
(Date:11/4/2014)...   3D scanner developer targets ... Fuel3D , a developer of 3D scanning solutions, today announced ... (£4 million). This funding builds on the company,s initial $2.6 ... the way for the commercial launch of the company,s consumer ... led by Chimera Partners and will be used to ramp-up ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... Researchers at the University of Newcastle, England, ... the United States have revealed a large reservoir of ... analysis of blood samples from almost 3,000 infants born ... in 200 individuals in the general public harbor mitochondrial ...
... the International Primatological Society (IPS) Lifetime Achievement Award for ... was presented at the 12th Congress of the IPS ... also be given the Leakey Prize for revolutionizing our ... Foundation. He shares the prize with Jane Goodall. Nishida ...
... While the CDC recently reported that more moms than ever ... moms do not stick with it as long as they ... breastfeed, the new Brigham Young University study found that only ... short of the federal government,s goal to hit 50 percent ...
Cached Biology News:Large reservoir of mitochondrial DNA mutations identified in humans 2Springer editor Toshisada Nishida winner of 2 prestigious primatology awards 2New breastfeeding study shows most moms quit early 2
(Date:11/21/2014)... , Nov. 20, 2014 /CNW/ - Aequus ... to announce that it has closed a brokered ... warrants for approximately C$3.7 million.  Cormark Securities Inc. ... in the Brokered Offering for a syndicate of ... PI Financial Corp. (collectively the "Agents"). Concurrently with ...
(Date:11/18/2014)... RPS Diagnostics (RPS®) – a developer ... its third annual partnership of the Centers for ... Antibiotics Week from November 17-23. , Get Smart ... to highlight the coordinated efforts of CDC, state ... partners to provide education about the importance of ...
(Date:11/18/2014)... 18, 2014 Alanda Software, a ... Reporting solutions, announced today that a top tier ... Consummate Providerâ„¢ solution in both the U.S. and ... SaaS based, Data Quality remediation portal, designed to ... party Providers improve their ability to capture, transmit ...
(Date:11/18/2014)... 18, 2014 Array Architects is proud ... expertise to the nation's hospitals and health systems. It ... those dedicating their careers to the advancement of both ... in her respective field, Laura Silvoy has been chosen ... 2014 Winter Simulation Conference. , Laura will present ...
Breaking Biology Technology:Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2
... Oct. 24 Favrille, Inc. (OTC,Bulletin Board: FVRL) announced ... for a reverse merger whereby Favrille would acquire,all of ... in a stock for stock merger that would result ... proposed transaction is,consummated on the terms set forth in ...
... five years after Jim Rider, the first American patient to receive ... patient milestone. , ... Bremen, Germany (PRWEB) October 24, ... worse, and the knowledge that many treatments are just not available ...
... p.m. EST, HOPKINTON, Mass., Oct. 23 ... conduct a conference call discussing the,company,s third quarter ... Monday,November 10. Kevin Hrusovsky, President and Chief Executive ... the call. Management will,discuss operational and financial results ...
Cached Biology Technology:Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2Stenum Hospital Does its 600th American Disc Replacement Surgery 2Caliper Life Sciences' Third Quarter 2008 Financial Results Conference Call Notice 2
Request Info...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Request Info...
... Rat Antibody to Human CD66 acd ... expressed by human neutrophils and cells ... Clone YTH71.3 reacts with transfectants containing ... CEA subfamily members(2). ...
Biology Products: